Iodixanol Versus Iopamidol in Patients Undergoing Contrast-Enhanced Computed Tomographic Imaging of Abdomen/Pelvis
Status:
Completed
Trial end date:
2012-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate and compare overall patient comfort profile between
the Iso-osmolar contrast media (IOCM), iodixanol 320 mg I/mL, and a Low-osmolar contrast
media (LOCM), iopamidol 370 mg I/mL in patients undergoing Contrast-Enhanced Computed
Tomographic (CECT) imaging of the abdomen/pelvis.